Vanguard Group »

Merrimack Pharma shares owned by Vanguard Group

Quarter-by-quarter ownership of Merrimack Pharma (MACK) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Merrimack Pharma

Tip: Access up to 7 years of quarterly data

All positions including Merrimack Pharma held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merrimack Pharma by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.2M 609k 13.41
2023-09-30 $7.4M 600k 12.33
2023-06-30 $6.8M 557k 12.30
2023-03-31 $5.6M 459k 12.29
2022-12-31 $6.7M 588k 11.46
2022-06-30 $3.6M 608k 5.95
2022-03-31 $3.8M 608k 6.32
2021-09-30 $3.0M 619k 4.83
2021-06-30 $3.8M 619k 6.21
2021-03-31 $3.8M 619k 6.21
2020-12-31 $4.2M 591k 7.09
2020-09-30 $2.0M 503k 4.00
2020-06-30 $1.7M 503k 3.31
2020-03-31 $1.1M 503k 2.15
2019-12-31 $1.6M 503k 3.15
2019-09-30 $2.2M 495k 4.42
2019-03-31 $1.5M 225k 6.84
2018-12-31 $820k 219k 3.75
2018-09-30 $2.9M 547k 5.30
2018-06-30 $2.6M 553k 4.62
2018-03-31 $4.8M 598k 8.05
2017-12-31 $6.7M 654k 10.24
2017-09-30 $9.2M 611k 15.00